Kristen Ambrose Sells $1.06M of Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Feb 19, 2026

Open-Market Net Sale · SEC Form 4

−$1,064,297

10b5-1 Plan (Partial)

Equity position changed by -11.3%

Reporting Owner

Kristen Ambrose

CAO

TXN 2026-02-18 · FILED 2026-02-19

Equity Position 7.75K sh 8,734 → 7,750

Equity Change -11.3% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Vertex Pharmaceuticals Inc MA

VRTX CIK 0000875320

Reporting Owner

Name	Relationship
Kristen Ambrose CIK 0001856587	CAO

Kristen Ambrose at Vertex Pharmaceuticals Inc MA Full insider history

Bought (12 mo) —

Sold (12 mo) $1,978,865

More from this insider at Vertex Pharmaceuticals Inc MA

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-02-17	A - Award/Grant	1,809 A	$0.00	—	10,543	Direct
Common Stock	2026-02-17	F - Tax Payment 10b5-1	598 D	$483.75	-$289,283	9,945	Direct
Common StockF2	2026-02-17	S - Sale 10b5-1	1,557 D	$489.46	-$762,089	8,388	Direct
Common StockF2	2026-02-18	S - Sale 10b5-1	638 D	$473.68	-$302,208	7,750	Direct

Footnotes (2)

F1: Restricted stock unit award that vests in installments beginning on February 20, 2027. Show more
F2: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Vertex Pharmaceuticals Inc MA

GET /v1/forms/4/0000875320-26-000080 API docs